22 studies found for:    Ustekinumab | Open Studies
Show Display Options
Rank Status Study
1 Recruiting A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Conditions: Colitis, Ulcerative;   Inflammatory Bowel Diseases
Interventions: Drug: Placebo IV;   Drug: Placebo SC;   Drug: Ustekinumab IV;   Drug: Ustekinumab SC
2 Recruiting Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris
Condition: Psoriasis
Interventions: Biological: Ustekinumab;   Biological: Abatacept;   Procedure: Placebo for Ustekinumab;   Drug: Placebo for Abatacept
3 Recruiting A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Ustekinumab IV;   Drug: Placebo Infusion;   Drug: Placebo SC;   Drug: Ustekinumab SC;   Other: Concomitant Medication
4 Recruiting A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Naive Participants With Active Radiographic Axial Spondyloarthritis
Condition: Axial Spondyloarthritis
Interventions: Drug: Placebo;   Drug: Ustekinumab 45 mg;   Drug: Ustekinumab 90 mg;   Drug: Golimumab 50 mg
5 Recruiting A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis
Condition: Axial Spondyloarthritis
Interventions: Drug: Placebo;   Drug: Ustekinumab 45 mg;   Drug: Ustekinumab 90 mg;   Drug: Golimumab 50 mg
6 Recruiting An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis
Condition: Nonradiographic Axial Spondylitis, Ankylosing
Interventions: Drug: Group 1: Placebo;   Drug: Group 2: Ustekinumab 45 mg;   Drug: Group 3: Ustekinumab 90 mg
7 Recruiting Exploratory Study on Tolerability and Safety of Adding Ustekinumab to INGAP Peptide for 12 Weeks in Adult Patients With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: INGAP Peptide, Ustekinumab
8 Recruiting Pilot Clinical Trial of Ustekinumab in Patients With New-onset T1D
Condition: Type 1 Diabetes
Intervention: Drug: Ustekinumab
9 Not yet recruiting Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease
Condition: Behçet Disease
Intervention: Drug: Subcutaneous Ustekinumab
10 Recruiting Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency
Conditions: CVID;   Enteropathy;   Chronic Diarrhea;   Maldigestion;   Malabsorption
Intervention: Biological: Ustekinumab
11 Unknown  A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
Conditions: Scalp Psoriasis;   Plaque Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Placebo
12 Recruiting Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)
Conditions: Psoriasis;   Cardiovascular Disease
Interventions: Drug: Ustekinumab;   Drug: Placebo
13 Recruiting A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: No Intervention
14 Recruiting Swiss Dermatology Network of Targeted Therapies (SDNTT)
Condition: Psoriasis
Interventions: Biological: Adalimumab;   Biological: Etanercept;   Biological: Infliximab;   Biological: Ustekinumab;   Drug: Cyclosporine A;   Drug: Fumaric acids;   Drug: Methotrexate;   Drug: Other anti-psoriatic systemic treatments
15 Recruiting A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: Ixekizumab;   Drug: Ustekinumab
16 Recruiting Stelara Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
Conditions: Psoriasis;   Pregnancy
Intervention:
17 Recruiting Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)
Condition: Psoriatic Arthritis
Interventions: Drug: Guselkumab;   Drug: Ustekinumab;   Drug: Placebo
18 Recruiting Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis
Condition: Psoriasis
Interventions: Drug: etanercept;   Drug: ustekinumab;   Drug: cyclosporine
19 Recruiting Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis
Conditions: Lupus;   Psoriasis
Interventions: Drug: BMS-986165;   Drug: Interferon alpha-2a recombinant;   Drug: Ustekinumab;   Drug: Famotidine;   Other: Placebo
20 Recruiting Spanish Registry of Systemic Treatments in Psoriasis
Condition: Psoriasis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Indicates status has not been verified in more than two years